The CGM market is an exciting, fast-growing, multibillion-dollar sector for the medical device industry, according to our latest Medtech Market Intelligence Report for MassDevice. The report on the CGM market — available for purchase on MassDevice — draws on numerous sources, including but not limited to: medical associations, government data, medical journals, leading medtech publications, clinical […]
minimed
Court sides with Medtronic in insulin pump class action suit
A Minnesota judge has dismissed a class action lawsuit alleging securities fraud related to insulin pumps made by Medtronic (NYSE:MDT). Laura M. Provinzino, U.S. District Judge for the District of Minnesota, granted Medtronic’s motion to dismiss the suit initially brought forward by investors in 2022. Provinzino’s dismissal comes about a year-and-a-half after Katherine M. Menendez, […]
Medtronic begins rollout of MiniMed 780G with Instinct sensor made by Abbott
Medtronic (NYSE:MDT) announced that its Instinct sensor, made by Abbott, is now available to order with the MiniMed 780G pump. The medtech giant’s diabetes unit — one of the largest diabetes tech businesses in the world — earlier this month picked up FDA clearance for its SmartGuard algorithm as an interoperable automated glycemic controller (iAGC). […]
Medtronic reports positive 3-year automated insulin delivery data
Medtronic (NYSE:MDT) today shared three-year real-world evidence highlighting improvements with its MiniMed 780G automated insulin delivery system. MiniMed 780G, the company’s latest-generation AID system, offers meal detection technology and provides automatic adjustments and corrections to sugar levels every five minutes. This occurs for both basal (background) and bolus (mealtime) insulin needs. Data demonstrated rapid, sustained […]
Medtronic gets FDA nods for MiniMed 780G with Abbott Instinct sensor, expansion to type 2
Medtronic (NYSE:MDT) announced today that the FDA granted two major approvals to broaden access to its MiniMed 780G system. First, the FDA granted clearance for its SmartGuard algorithm as an interoperable automated glycemic controller (iAGC). This enables integration with a sensor made by Abbott, designed specifically through a collaboration between the medtech giants. Second, the […]
Medtronic says MiniMed separation remains on track, next-gen pump submissions on the way
Medtronic (NYSE:MDT) officials today said that the company’s planned separation of its Diabetes business is on the right track. The medtech giant announced in May that it planned to separate the Diabetes unit into a standalone, publicly traded company. The move sought to create “a more focused Medtronic” with a more simplified portfolio in high-margin growth markets. […]
Medtronic issues CGM app warning in Spain
The Spanish Agency for Medicines and Medical Devices (AEMPS) has received notice of potential accessibility issues with Medtronic CGM apps. Medtronic Diabetes — soon to be MiniMed after its planned separation from the medtech giant – contacted users of certain Samsung Galaxy A13 smartphone devices, as those are used as a Medtronic smart monitoring receiver with […]
Medtronic Diabetes shares preview of new Abbott sensor made for MiniMed insulin delivery systems
The Medtronic Diabetes business today took to social media to share an early preview of a new integrated Abbott sensor for its insulin delivery systems. Medtronic Diabetes — soon to be MiniMed after its planned separation from the medtech giant – said in the post that the new sensor specifically designed for its own systems […]
The 10 largest diabetes technology companies in the world
What has changed in the last year as diabetes technology developers continue to innovate and advance their offerings? We are seeing the industry form an intriguing niche at the intersection of medtech and consumer devices. Various companies around the world are delivering numerous options when it comes to the type of technology they want to […]
Medtronic MiniMed 780G wins CE mark for type 2 diabetes, young children
Medtronic (NYSE:MDT) announced today that it received CE mark to expand its MiniMed 780G’s indications, including for type 2 diabetes. The expansion brings the automated insulin delivery (AID) system to individuals aged 2 years and older with type 1 diabetes. It also enables the use of MiniMed 780G during pregnancy and by those with type […]
